Original Research

Published on 10 May 2023

Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort

in Cancer Immunity and Immunotherapy

Lin Wu
Jun Yang
Peng She
Fanzhi Kong
Zhenwei Mao
Shengjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1195520

2,930 views
3 citations

Original Research

Published on 10 May 2023

Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)

in Cancer Immunity and Immunotherapy

Sant P. Chawla
Walter Andree Tellez
Hripsime Chomoyan
Chrysler Valencia
Amir Ahari
Nadezhda Omelchenko
Stefan Makrievski
Don A. Brigham
Victoria Chua-Alcala
Doris Quon

Frontiers in Oncology

doi 10.3389/fonc.2023.1116937

2,404 views
5 citations

Review

Published on 10 May 2023

Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications

in Cancer Immunity and Immunotherapy

Yuting Li
Xiaofan Gao
Yibao Huang
Xiaoran Zhu
Yingying Chen
Liru Xue
Qingqing Zhu
Bo Wang
Mingfu Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1114042

2,755 views
7 citations

Original Research

Published on 09 May 2023

Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer

in Cancer Immunity and Immunotherapy

Youqun Huang
Xingxing Lei
Lisha Sun
Yu Liu
Jiao Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1163695

1,698 views
1 citation

Original Research

Published on 09 May 2023

Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas

in Cancer Immunity and Immunotherapy

Youjun Li
Xiaobo Li
Zhengtao Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1177120

1,972 views
2 citations

Original Research

Published on 05 May 2023

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases

in Cancer Immunity and Immunotherapy

Chunyu Wang
Shuai Mu
Xuhui Yang
Lingling Li
Haitao Tao
Fan Zhang
Ruixin Li
Yi Hu
Lijie Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1110949

1,389 views
3 citations

Original Research

Published on 03 May 2023

Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial

in Cancer Immunity and Immunotherapy

Cláudia S. Ferreira
Galina Babitzki
Irina Klaman
Oliver Krieter
Katharina Lechner
Johanna Bendell
Suzana Vega Harring
Florian Heil

Frontiers in Oncology

doi 10.3389/fonc.2023.1157596

4,683 views
4 citations

Original Research

Published on 03 May 2023

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Silje Beckinger
Tina Daunke
Leon Aldag
Sandra Krüger
Steffen Heckl
Daniela Wesch
Heiner Schäfer
Christoph Röcken
Sascha Rahn
Susanne Sebens

Frontiers in Oncology

doi 10.3389/fonc.2023.1160824

3,113 views
6 citations

Review

Published on 03 May 2023

The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment

in Cancer Immunity and Immunotherapy

Francesca Pontis
Luca Roz
Orazio Fortunato
Giulia Bertolini

Frontiers in Oncology

doi 10.3389/fonc.2023.1116783

3,040 views
4 citations

Original Research

Published on 02 May 2023

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

in Cancer Immunity and Immunotherapy

Jeffrey R. Whiteaker
Lei Zhao
Regine M. Schoenherr
Dongqing Huang
Rachel A. Lundeen
Ulianna Voytovich
Jacob J. Kennedy
Richard G. Ivey
Chenwei Lin
Oscar D. Murillo

Frontiers in Oncology

doi 10.3389/fonc.2023.1168710

3,077 views
2 citations

Original Research

Published on 02 May 2023

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Jian Shangguan
Xinyi Huang
Xu Liu
Zengfu Zhang
Xiaodong Zhang
Jinming Yu
Dawei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1195499

2,437 views
7 citations

Review

Published on 01 May 2023

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

in Cancer Immunity and Immunotherapy

Minhan Jiang
Steven Fiering
Qi Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1153066

3,084 views
6 citations

Mini Review

Published on 28 Apr 2023

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lingli Luo
Yuxin Liu
Jingfen Lu
Yifei Zhang
Gang Fan
Xiaojun Tang
Weiming Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1104888

2,578 views

Case Report

Published on 28 Apr 2023

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

in Cancer Immunity and Immunotherapy

Jiabao Yang
Pengfei Xing
Yuehong Kong
Meiling Xu
Liyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078915

3,027 views
5 citations

Review

Published on 28 Apr 2023

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives

in Cancer Immunity and Immunotherapy

Shuang Zhang
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1142081

10,679 views
11 citations

Review

Published on 27 Apr 2023

IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation

in Cancer Immunity and Immunotherapy

Alexander J. Muller
Arpita Mondal
Souvik Dey
George C. Prendergast

Frontiers in Oncology

doi 10.3389/fonc.2023.1165298

2,745 views
11 citations

Navigation group

Articles

Single-cell RNA sequencing and traditional RNA sequencing reveals the role of cancer-associated fibroblasts in oral squamous cell carcinoma cohort

Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)

Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications

Leveraging various extracellular matrix levels to assess prognosis and sensitivity to immunotherapy in patients with ovarian cancer

Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases

Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma

The metastatic niche formation: focus on extracellular vesicle-mediated dialogue between lung cancer cells and the microenvironment

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study

Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives

IDO1 and inflammatory neovascularization: bringing new blood to tumor-promoting inflammation